News Oct 11, 2024
Alimentiv Showcases End-to-End GI Research Solutions and Innovation With Four Poster Presentations at UEG Week 2024

London, Ontario, Canada, October 11, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce four poster presentations at the United European Gastroenterology (UEG) conference taking…

Article May 30, 2024
Alimentiv DDW 2024 Presentations

If you’ve missed some of our lecture presentations and poster sessions, reach out for more information….

News May 13, 2024
Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease…

Article Mar 19, 2024
Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide,…

Article Jan 10, 2024
Bayesian innovations to supplement open-label trials

Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase…

News Jan 8, 2024
Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective…